+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mouse Model for Drug Screening & Evaluation Market - Global Forecast 2026-2032- Product Image
Mouse Model for Drug Screening & Evaluation Market - Global Forecast 2026-2032- Product Image
Sale

Mouse Model for Drug Screening & Evaluation Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6147188
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mouse Model for Drug Screening & Evaluation Market is projected to reach USD 784.60 Million in 2026. It is expected to continue growing at a CAGR of 7.32%, reaching USD 1.19 Billion by 2032.

Mouse Models Anchor Translational Drug Screening and Evaluation

Mouse models remain a foundational tool for evaluating pharmacology, toxicology, efficacy, disease mechanisms, and biomarker relationships before human studies. Their value comes from combining controlled genetics and environments with measurable physiological and behavioral endpoints. However, findings must be interpreted alongside species differences, model-specific limitations, and complementary human-relevant methods. Effective programs increasingly position mouse studies within integrated evidence packages rather than treating them as standalone validation.

Demand is shaped by therapeutic complexity, regulatory expectations, reproducibility requirements, and the need to identify safety or efficacy risks earlier. Standardized protocols, rigorous controls, transparent reporting, and careful model selection are therefore central to credible decision-making. Applications span oncology, immunology, infectious disease, neuroscience, metabolic disorders, and rare diseases, with approaches ranging from conventional strains to genetically engineered, humanized, and patient-derived models.

Translational Rigor and Model Diversity Are Reshaping Preclinical Research

The landscape is shifting from broad reliance on traditional inbred strains toward fit-for-purpose model portfolios. Genetically engineered mice, humanized systems, immunocompromised hosts, patient-derived xenografts, and models incorporating sex, age, and comorbidity diversity can address questions that conventional designs may not capture. At the same time, improved study registration, randomization, blinding, power calculations, and independent replication are raising expectations for reproducibility.

Ethical governance is also becoming more consequential. The principles of replacement, reduction, and refinement encourage researchers to limit animal use while improving welfare and information yield. Imaging, longitudinal sampling, microsampling, organoid comparisons, and computational analysis can help extract more data from each study. These changes favor organizations that connect model selection, experimental design, data quality, and translational interpretation from the outset.

Artificial Intelligence Accelerates Design, Analysis, and Translational Interpretation

Artificial intelligence is increasingly applied to select experimental models, prioritize compounds, analyze images, classify phenotypes, and identify relationships across multimodal datasets. Computer vision can support more consistent assessment of tumor burden, tissue pathology, movement, behavior, and cellular responses, while machine-learning workflows can integrate molecular, clinical, and preclinical information to improve hypothesis generation.

The strongest value arises when AI augments-not replaces-experimental judgment. Training-data quality, annotation consistency, external validation, explainability, and bias control remain essential. Models developed from narrow strain, sex, laboratory, or disease datasets may perform poorly when transferred elsewhere. Leaders should establish governance covering data provenance, version control, model performance, human review, and reproducibility, while using AI to reduce avoidable variability and prioritize the most informative studies.

Regional Priorities Reflect Different Research Infrastructures and Regulatory Contexts

In North America, sophisticated biomedical infrastructure, translational partnerships, and strong emphasis on reproducibility support advanced genetically engineered, humanized, imaging, and data-rich mouse studies. Latin America is shaped by uneven access to specialized facilities, growing academic and public-sector research capacity, and the importance of scalable protocols, local disease priorities, and collaborative platforms.

Europe combines substantial pharmaceutical and academic capability with strong animal-welfare expectations, harmonized regulatory principles, and continued interest in alternatives and refinement. The Middle East is developing biomedical research capacity through investment in health science, precision medicine, and specialized facilities, while workforce development and cross-border collaboration remain important. Africa presents opportunities tied to infectious disease, neglected conditions, and locally relevant translational research, alongside infrastructure, funding, and access constraints. Asia-Pacific includes highly advanced research ecosystems as well as rapidly developing markets, with priorities spanning oncology, immunology, metabolic disease, infectious disease, and precision medicine. Across all regions, quality systems, skilled personnel, and interoperable data practices determine whether mouse-model findings translate effectively.

International Groups Shape Collaboration, Standards, and Research Access

The ASEAN countries can benefit from shared infrastructure, harmonized training, and regional study networks that address infectious disease, metabolic health, and locally relevant conditions. BRICS collaboration can broaden access to capabilities, strengthen comparative research, and support model development for diverse populations, provided that data standards and ethical oversight are aligned.

The European Union emphasizes coordinated regulation, animal-welfare safeguards, and alternatives-oriented innovation. The G7 provides a platform for advanced research cooperation, biosecurity dialogue, and reproducibility practices. The GCC is investing in biomedical capacity and can accelerate specialized preclinical research through coordinated facilities and international partnerships. NATO members and associated research networks have particular incentives to strengthen preparedness for infectious disease, biological threats, and medical countermeasure development while maintaining strict governance and responsible-use controls.

Country Capabilities Differ in Scale, Specialization, and Translational Priorities

The United States combines deep academic, biotechnology, and pharmaceutical capabilities with extensive demand for rigorous translational evidence. Canada contributes strong public research, disease-model expertise, and collaborative networks. Mexico is expanding biomedical capacity, with opportunities to strengthen standardized facilities, training, and cross-border partnerships. Brazil has substantial academic and public-health expertise, particularly for infectious, tropical, and chronic diseases, while infrastructure consistency remains important.

In Europe, France, Germany, Italy, Spain, and the United Kingdom support diverse preclinical programs within demanding welfare, quality, and regulatory environments. Russia retains expertise in biomedical research but faces constraints related to international access, collaboration, and supply continuity. In Asia, China, Japan, South Korea, India, and Australia offer distinct strengths: China in scale and model development; Japan in advanced biomedical research and aging-related science; South Korea in biotechnology and translational innovation; India in expanding research capacity and disease-focused programs; and Australia in high-quality biomedical science, infectious-disease research, and strong institutional governance. Country-level execution depends on facility standards, talent, procurement, regulatory clarity, and access to validated model systems.

Industry Leaders Should Build Evidence Portfolios, Not Isolated Mouse Studies

Leaders should begin with a decision-oriented model strategy: define the biological question, translational endpoint, target population, and failure criteria before selecting a strain or platform. Use complementary models when one system cannot represent human heterogeneity, and predefine how results will be integrated with human cells, organoids, pharmacokinetics, biomarkers, and computational analyses.

Invest in reproducibility through randomization, blinding, appropriate controls, preregistered protocols where suitable, power analysis, independent replication, and transparent reporting. Establish digital data standards that preserve metadata, images, sample lineage, and analytical decisions. Apply AI selectively with documented validation and human oversight. Finally, strengthen partnerships with accredited facilities and specialist laboratories, maintain contingency plans for animals and critical reagents, and measure programs by decision quality, translational relevance, welfare performance, and time saved-not by study volume alone.

Methodology Combines Structured Secondary Evidence With Translational Interpretation

This executive summary uses the defined market scope-mouse models used for drug screening and evaluation-and organizes analysis around application needs, model types, research workflows, technology adoption, regulation, ethics, and geographic capability. The assessment integrates established principles from preclinical pharmacology, toxicology, laboratory-animal science, translational medicine, data governance, and reproducibility research.

Insights are synthesized comparatively across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific; ASEAN, BRICS, the European Union, G7, GCC, and NATO; and the specified countries. Because the scope excludes estimates, sizing, shares, forecasts, and company profiling, conclusions focus on verified structural drivers, operational requirements, regional characteristics, and evidence-quality considerations. Interpretations should be updated as regulations, technologies, disease priorities, and institutional capabilities change.

The Next Advantage Will Come From Better Translation, Reproducibility, and Integration

Mouse models will remain important because they connect molecular hypotheses with whole-organism pharmacology, safety, and disease biology. Their future effectiveness will depend less on using more models and more on selecting the right model, measuring the right endpoints, and acknowledging where mouse biology does not represent human disease.

Organizations that combine rigorous experimental design, welfare-conscious practice, AI-enabled analysis, complementary human-relevant systems, and transparent data workflows will be better positioned to make reliable development decisions. Regional and international collaboration can further improve access, standardization, and preparedness. The central strategic priority is an integrated translational framework in which mouse evidence is credible, reproducible, appropriately qualified, and connected to the human questions that ultimately determine therapeutic value.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Mouse Model for Drug Screening & Evaluation Market, by Product Type
7.1. Introduction
7.2. Consumables
7.2.1. Disposables
7.2.2. Kits & Assays
7.2.3. Media & Reagents
7.3. Instruments
7.4. Software & Services
8. Mouse Model for Drug Screening & Evaluation Market, by Model Type
8.1. Introduction
8.2. Genetically Engineered
8.2.1. CRISPR/Cas9
8.2.2. Knockin
8.2.3. Knockout
8.2.4. Transgenic
8.3. Humanized
8.4. Syngeneic
8.5. Xenograft
9. Mouse Model for Drug Screening & Evaluation Market, by Animal Species
9.1. Introduction
9.2. Athymic Nude
9.3. BALB/c
9.4. C57BL/6
9.5. SCID
10. Mouse Model for Drug Screening & Evaluation Market, by Application
10.1. Introduction
10.2. Cardiovascular Diseases
10.3. CNS Disorders
10.4. Infectious Diseases
10.5. Metabolic Disorders
10.6. Oncology
11. Mouse Model for Drug Screening & Evaluation Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. CROs
11.4. Pharmaceutical & Biotech Companies
12. Mouse Model for Drug Screening & Evaluation Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Mouse Model for Drug Screening & Evaluation Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Mouse Model for Drug Screening & Evaluation Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Applied StemCell, Inc.
16.2. Beijing Vitalstar Biotechnology Co., Ltd.
16.3. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
16.4. BioIVT, Inc
16.5. Charles River Laboratories International, Inc.
16.6. Crown Bioscience International, Inc.
16.7. Cyagen Biosciences, Inc.
16.8. Envigo, Inc.
16.9. GemPharmatech Co., Ltd.
16.10. genOway SAS
16.11. Horizon Discovery Group Limited
16.12. Ingenious Targeting Laboratory, Inc.
16.13. Inotiv, Inc.
16.14. Janvier Labs
16.15. MD Anderson Cancer Center
16.16. Oriental BioService, Inc.
16.17. Regeneron Pharmaceuticals, Inc.
16.18. SAGE Labs, Inc.
16.19. Shanghai Biomodel Organism Science & Technology Development Co., Ltd.
16.20. Shanghai Model Organisms Center, Inc.
16.21. Taconic Biosciences, Inc.
16.22. The Jackson Laboratory
16.23. Transgenic, Inc.
16.24. University of California, Davis
16.25. Yecuris, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Mouse Model for Drug Screening & Evaluation Market, Years Considered for the Study
FIGURE 2. Global Mouse Model for Drug Screening & Evaluation Market, Research Design
FIGURE 3. Global Mouse Model for Drug Screening & Evaluation Market, Research Framework
FIGURE 4. Global Mouse Model for Drug Screening & Evaluation Market, Data Triangulation
FIGURE 5. Global Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2025 vs 2032 (%)
FIGURE 9. Global Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2025 vs 2032 (%)
FIGURE 11. Global Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Mouse Model for Drug Screening & Evaluation Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Mouse Model for Drug Screening & Evaluation Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Mouse Model for Drug Screening & Evaluation Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Mouse Model for Drug Screening & Evaluation Market Segmentation & Coverage
TABLE 2. Global Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 3. Global Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Disposables Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Disposables Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Disposables Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Kits & Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Kits & Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Kits & Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Media & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Media & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Media & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 23. Global Genetically Engineered Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Genetically Engineered Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Genetically Engineered Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global CRISPR/Cas9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global CRISPR/Cas9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global CRISPR/Cas9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Knockin Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Knockin Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Knockin Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Knockout Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Knockout Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Knockout Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Transgenic Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Transgenic Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Transgenic Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Humanized Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Humanized Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Humanized Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Syngeneic Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Syngeneic Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Syngeneic Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Xenograft Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Xenograft Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Xenograft Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 48. Global Athymic Nude Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Athymic Nude Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Athymic Nude Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global BALB/c Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global BALB/c Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global BALB/c Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global C57BL/6 Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global C57BL/6 Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global C57BL/6 Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global SCID Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global SCID Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global SCID Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 61. Global Cardiovascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Cardiovascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Cardiovascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global CNS Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global CNS Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global CNS Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Pharmaceutical & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Pharmaceutical & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Pharmaceutical & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. North America Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. North America Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. North America Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 98. North America Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 99. North America Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 100. North America Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 101. North America Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. North America Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 106. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 107. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 108. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 109. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Latin America Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Europe Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Europe Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Europe Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 114. Europe Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 115. Europe Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 116. Europe Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 117. Europe Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Europe Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 122. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 123. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 124. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 125. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Middle East Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Africa Mouse Model for Drug Screening & Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Africa Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. Africa Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 130. Africa Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 131. Africa Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 132. Africa Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 133. Africa Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Africa Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Global Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 139. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 140. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 141. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 142. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. ASEAN Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. GCC Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. GCC Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. GCC Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 147. GCC Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 148. GCC Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 149. GCC Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 150. GCC Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. GCC Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. European Union Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. European Union Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. European Union Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 155. European Union Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 156. European Union Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 157. European Union Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 158. European Union Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. European Union Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 163. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 164. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 165. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 166. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. BRICS Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. G7 Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. G7 Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. G7 Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 171. G7 Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 172. G7 Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 173. G7 Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 174. G7 Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. G7 Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. NATO Mouse Model for Drug Screening & Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. NATO Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. NATO Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 179. NATO Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 180. NATO Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 181. NATO Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 182. NATO Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. NATO Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Global Mouse Model for Drug Screening & Evaluation Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. United States Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 186. United States Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. United States Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 188. United States Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 189. United States Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 190. United States Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 191. United States Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. United States Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Canada Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 194. Canada Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. Canada Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 196. Canada Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 197. Canada Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 198. Canada Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 199. Canada Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Canada Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Mexico Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 202. Mexico Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Mexico Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 204. Mexico Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 205. Mexico Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 206. Mexico Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 207. Mexico Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Mexico Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Brazil Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 210. Brazil Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Brazil Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 212. Brazil Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 213. Brazil Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 214. Brazil Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 215. Brazil Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Brazil Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 218. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 220. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 221. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 222. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 223. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. United Kingdom Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Germany Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 226. Germany Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. Germany Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 228. Germany Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 229. Germany Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 230. Germany Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 231. Germany Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Germany Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. France Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 234. France Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. France Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 236. France Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 237. France Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 238. France Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 239. France Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. France Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Russia Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 242. Russia Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. Russia Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 244. Russia Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 245. Russia Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 246. Russia Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 247. Russia Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. Russia Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Italy Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 250. Italy Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. Italy Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 252. Italy Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 253. Italy Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 254. Italy Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 255. Italy Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Italy Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Spain Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 258. Spain Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. Spain Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 260. Spain Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 261. Spain Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 262. Spain Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 263. Spain Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. Spain Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. China Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 266. China Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 267. China Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 268. China Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 269. China Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 270. China Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 271. China Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. China Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. India Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 274. India Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. India Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 276. India Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 277. India Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 278. India Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 279. India Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. India Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. Japan Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 282. Japan Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. Japan Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 284. Japan Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 285. Japan Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 286. Japan Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 287. Japan Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. Japan Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Australia Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 290. Australia Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. Australia Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 292. Australia Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 293. Australia Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 294. Australia Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 295. Australia Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. Australia Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. South Korea Mouse Model for Drug Screening & Evaluation Market Size, 2017-2032 (USD Million)
TABLE 298. South Korea Mouse Model for Drug Screening & Evaluation Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. South Korea Mouse Model for Drug Screening & Evaluation Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 300. South Korea Mouse Model for Drug Screening & Evaluation Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 301. South Korea Mouse Model for Drug Screening & Evaluation Market Size, by Genetically Engineered, 2017-2032 (USD Million)
TABLE 302. South Korea Mouse Model for Drug Screening & Evaluation Market Size, by Animal Species, 2017-2032 (USD Million)
TABLE 303. South Korea Mouse Model for Drug Screening & Evaluation Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. South Korea Mouse Model for Drug Screening & Evaluation Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Global Mouse Model for Drug Screening & Evaluation Market Share, by Key Player, 2025
TABLE 306. Global Mouse Model for Drug Screening & Evaluation Market, Key Experts

Companies Mentioned

  • Applied StemCell, Inc.
  • Beijing Vitalstar Biotechnology Co., Ltd.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  • BioIVT, Inc
  • Charles River Laboratories International, Inc.
  • Crown Bioscience International, Inc.
  • Cyagen Biosciences, Inc.
  • Envigo, Inc.
  • GemPharmatech Co., Ltd.
  • genOway SAS
  • Horizon Discovery Group Limited
  • Ingenious Targeting Laboratory, Inc.
  • Inotiv, Inc.
  • Janvier Labs
  • MD Anderson Cancer Center
  • Oriental BioService, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • SAGE Labs, Inc.
  • Shanghai Biomodel Organism Science & Technology Development Co., Ltd.
  • Shanghai Model Organisms Center, Inc.
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • Transgenic, Inc.
  • University of California, Davis
  • Yecuris, Inc.

Related Topics

Related Reports

Rat & Mouse Model Market - Global Forecast 2026-2032 - Product Image

Rat & Mouse Model Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Knock Out Mouse Model - Global Strategic Business Report - Product Image

Knock Out Mouse Model - Global Strategic Business Report

  • Report
  • 368 Pages
  • Global
From
Knock Out Mouse Model Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Knock Out Mouse Model Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Humanized Mouse Model Market Outlook 2026-2034: Market Share and Growth Analysis - Product Image

Humanized Mouse Model Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Mice Model - Global Strategic Business Report - Product Image

Mice Model - Global Strategic Business Report

  • Report
  • 385 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.